Oracle
ORCL
Amazon
AMZN
Coinbase
COIN
Adobe
ADBE
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
EVAX Evaxion Biotech
- 2.765
- -0.325-10.52%
Trading Jan 21 13:28 ET
3.24MMarket Cap-0.20P/E (TTM)
3.460High2.718Low115.49KVolume3.140Open3.090Pre Close345.34KTurnover15.73%Turnover RatioLossP/E (Static)1.17MShares36.90052wk High43.89P/B2.03MFloat Cap2.71852wk Low--Dividend TTM734.42KShs Float1252.000Historical High--Div YieldTTM24.00%Amplitude2.718Historical Low2.990Avg Price1Lot Size
Evaxion Biotech News
Evaxion Biotech Analyst Ratings
H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14
H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14
Evaxion Biotech Gains Buy Rating Amid Merck Collaboration and AI-Driven Vaccine Development Prospects
Evaxion Biotech Price Target Maintained With a $14.00/Share by HC Wainwright & Co.
Evaxion Biotech Analyst Ratings
Lake Street Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $7
Evaxion Biotech (EVAX) Gets a Buy From Lake Street
Evaxion Biotech Analyst Ratings
H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14
Buy Rating for Evaxion Biotech Supported by Strong Clinical Results and PIONEER Platform's Potential
Evaxion Biotech Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Evaxion Biotech, Maintains $14 Price Target
H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14
Buy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical Trials
Evaxion Biotech Analyst Ratings
H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14
Evaxion Biotech Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evaxion Biotech (EVAX), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Genprex (GNPX)
Evaxion Biotech Analyst Ratings
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.